CL
LAB icon

CSS LLC’s Standard BioTools LAB Stock Holding History

CSS LLC’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40,000
Closed -$236K – 582
2017
Q4 		$236K Sell
40,000
-59,300
-60% -$325K 0.01% 461
2017
Q3 		$501K Buy
99,300
+24,000
+32% +$101K 0.02% 351
2017
Q2 		$304K Buy
75,300
+59,300
+371% +$281K 0.01% 440
2017
Q1 		$91K Buy
16,000
+6,000
+60% +$38K 0.01% 571
2016
Q4 		$73K Buy
+10,000
New +$62.8K ﹤0.01% 631
2016
Q3 		– Sell
-10,000
Closed -$90K – 763
2016
Q2 		$90K Sell
10,000
-12,200
-55% -$115K 0.01% 636
2016
Q1 		$179K Sell
22,200
-10,000
-31% -$72.1K 0.01% 535
2015
Q4 		$348K Buy
+32,200
New +$316K 0.02% 433

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

CSS LLC's LAB Position: Q1 2018 in Review

CSS LLC sold out of Standard BioTools (LAB) in Q1 2018, closing a stake of 5,080 shares — an estimated $30K sold.

CSS LLC first reported a position in LAB in Q4 2017 and held it in 1 quarter. The position peaked at $30K in Q4 2017. 84 funds tracked by Wall St. Rank hold LAB as of Q1 2018.

  • CSS LLC reported no remaining Standard BioTools position as of Q1 2018 after selling out during the quarter.
  • CSS LLC sold 5,080 Standard BioTools shares in Q1 2018, an estimated $30K.
  • CSS LLC first reported a position in Standard BioTools in Q4 2017 and held it in 1 quarter.
  • CSS LLC's Standard BioTools position peaked at $30K in Q4 2017.
  • 84 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2018.

Based on CSS LLC's 13F filing for Q1 2018, filed 15 May 2018.